0001775697-24-000368.txt : 20240418 0001775697-24-000368.hdr.sgml : 20240418 20240418062444 ACCESSION NUMBER: 0001775697-24-000368 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240418 DATE AS OF CHANGE: 20240418 PERIOD START: 20240531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon Sustainable U.S. Equity Fund, Inc. CENTRAL INDEX KEY: 0000030167 ORGANIZATION NAME: IRS NUMBER: 132691318 STATE OF INCORPORATION: MD FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02192 FILM NUMBER: 24852745 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: Dreyfus Sustainable U.S. Equity Fund, Inc. DATE OF NAME CHANGE: 20170501 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS THIRD CENTURY FUND, INC DATE OF NAME CHANGE: 20161220 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS THIRD CENTURY FUND INC DATE OF NAME CHANGE: 20081201 0000030167 S000000095 BNY Mellon Sustainable U.S. Equity Fund, Inc. C000000149 Class A DTCAX C000000151 Class C DTCCX C000000152 Class I DRTCX C000000154 Class Z DRTHX C000174003 Class Y DTCYX NPORT-P 1 primary_doc.xml NPORT-P false 0000030167 XXXXXXXX S000000095 C000000149 C000000151 C000000152 C000000154 C000174003 BNY Mellon Sustainable U.S. Equity Fund, Inc. 811-02192 0000030167 549300QQ876PDFBOND85 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon Sustainable U.S. Equity Fund, Inc. S000000095 549300QQ876PDFBOND85 2024-05-31 2024-02-29 N 445268429.38 388487.75 444879941.63 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 N 0 0 ECOLAB INC 82DYEISM090VG8LTLS26 ECOLAB INC 278865100 28426.00 NS USD 6391301.84 1.4366352001807 Long EC CORP US N 1 N N N TEXAS INSTRUMENTS INC WDJNR2L6D8RWOEB8T652 TEXAS INSTRUMENTS INC 882508104 28535.00 NS USD 4774761.55 1.0732696854134 Long EC CORP US N 1 N N N BOSTON SCIENTIFIC CORP Y6ZDD9FP4P8JSSJMW954 BOSTON SCIENTIFIC CORP 101137107 205921.00 NS USD 13634029.41 3.0646536591526 Long EC CORP US N 1 N N N UNITEDHEALTH GROUP INC 549300GHBMY8T5GXDE41 UNITEDHEALTH GROUP INC 91324P102 14195.00 NS USD 7006652.00 1.5749534524591 Long EC CORP US N 1 N N N HUBBELL INC 54930088VDQ6840Y6597 HUBBELL INC 443510607 20076.00 NS USD 7642330.92 1.7178411982341 Long EC CORP US N 1 N N N PROGRESSIVE CORP 529900TACNVLY9DCR586 PROGRESSIVE CORP/THE 743315103 51357.00 NS USD 9735232.92 2.1882831768793 Long EC CORP US N 1 N N N PEPSICO INC FJSUNZKFNQ5YPJ5OT455 PEPSICO INC 713448108 61724.00 NS USD 10205446.16 2.2939775892363 Long EC CORP US N 1 N N N VERALTO CORP 635400FJE6GSOJUSNY27 VERALTO CORP 92338C103 37643.00 NS USD 3253108.06 0.7312328013892 Long EC CORP US N 1 N N N INTUIT INC VI90HBPH7XSFMB9E4M29 INTUIT INC 461202103 19087.00 NS USD 12652581.43 2.8440440321139 Long EC CORP US N 1 N N N DARLING INGREDIENTS INC L1N0SPPKS7EXZYUMZ898 DARLING INGREDIENTS INC 237266101 98735.00 NS USD 4177477.85 0.9390124074135 Long EC CORP US N 1 N N N LULULEMON ATHLETICA INC 549300D9GZ4BMLDW5T40 LULULEMON ATHLETICA INC 550021109 14572.00 NS USD 6806435.48 1.5299488340746 Long EC CORP US N 1 N N N NEXTERA ENERGY INC 254900RHL9MEUS5NKX63 NEXTERA ENERGY INC 65339F101 109556.00 NS USD 6046395.64 1.359107272368 Long EC CORP US N 1 N N N ABBVIE INC FR5LCKFTG8054YNNRU85 ABBVIE INC 00287Y109 65893.00 NS USD 11600462.65 2.6075490406461 Long EC CORP US N 1 N N N DANAHER CORP S4BKK9OTCEWQ3YHPFM11 DANAHER CORP 235851102 39747.00 NS USD 10061555.58 2.2616339013027 Long EC CORP US N 1 N N N FIRST HORIZON CORP TF3RXI1ZB1TQ30H9JV10 FIRST HORIZON CORP 320517105 281479.00 NS USD 3968853.90 0.8921179690544 Long EC CORP US N 1 N N N ELI LILLY & CO FRDRIPF3EKNDJ2CQJL29 ELI LILLY & CO 532457108 17388.00 NS USD 13104987.84 2.9457358297576 Long EC CORP US N 1 N N N GOLDMAN SACHS GROUP INC 784F5XWPLTWKTBV3E584 GOLDMAN SACHS GROUP INC/THE 38141G104 25909.00 NS USD 10079896.45 2.2657565573912 Long EC CORP US N 1 N N N TE CONNECTIVITY LTD 894500ZRIX9K13RHXR17 TE CONNECTIVITY LTD N/A 50240.00 NS USD 7212454.40 1.6212136635277 Long EC CORP CH N 1 N N N MICRON TECHNOLOGY INC B3DXGBC8GAIYWI2Z0172 MICRON TECHNOLOGY INC 595112103 63592.00 NS USD 5762071.12 1.2951968791598 Long EC CORP US N 1 N N N JPMORGAN CHASE & CO 8I5DZWZKVSZI1NUHU748 JPMORGAN CHASE & CO 46625H100 80069.00 NS USD 14897638.14 3.3486873077299 Long EC CORP US N 1 N N N APPLIED MATERIALS INC 41BNNE1AFPNAZELZ6K07 APPLIED MATERIALS INC 038222105 45326.00 NS USD 9138628.12 2.0541785018485 Long EC CORP US N 1 N N N ROPER TECHNOLOGIES INC 54930003T4SXCIWVXY35 ROPER TECHNOLOGIES INC 776696106 16722.00 NS USD 9108975.06 2.0475130945723 Long EC CORP US N 1 N N N JOHNSON CONTROLS INTERNATIONAL PLC 549300XQ6S1GYKGBL205 JOHNSON CONTROLS INTERNATIONAL PLC N/A 126851.00 NS USD 7518458.77 1.6899972478986 Long EC CORP IE N 1 N N N DEXCOM INC 549300YSK3QDSFR5EU59 DEXCOM INC 252131107 45723.00 NS USD 5261345.61 1.1826439265215 Long EC CORP US N 1 N N N BIOMARIN PHARMACEUTICAL NSLL8ITTRR0J5HEMR848 BIOMARIN PHARMACEUTICAL INC 09061G101 43257.00 NS USD 3732213.96 0.8389261035967 Long EC CORP US N 1 N N N ZOETIS INC 549300HD9Q1LOC9KLJ48 ZOETIS INC 98978V103 34059.00 NS USD 6754921.47 1.5183695280238 Long EC CORP US N 1 N N N TRANE TECHNOLOGIES PLC 549300BURLR9SLYY2705 TRANE TECHNOLOGIES PLC N/A 30166.00 NS USD 8505907.02 1.9119556141 Long EC CORP IE N 1 N N N PTC INC 54930050SSMU8SKDJ030 PTC INC 69370C100 29347.00 NS USD 5370794.47 1.2072458134034 Long EC CORP US N 1 N N N WASTE MANAGEMENT INC 549300YX8JIID70NFS41 WASTE MANAGEMENT INC 94106L109 39995.00 NS USD 8224971.75 1.8488070556439 Long EC CORP US N 1 N N N AKAMAI TECHNOLOGIES INC OC1LZNN2LF5WTJ5RIL89 AKAMAI TECHNOLOGIES INC 00971T101 56345.00 NS USD 6249787.40 1.4048256203912 Long EC CORP US N 1 N N N RENAISSANCERE HOLDINGS LTD EK6GB9U3U58PDI411C94 RENAISSANCERE HOLDINGS LTD N/A 36213.00 NS USD 8141406.66 1.8300233159918 Long EC CORP BM N 1 N N N MASTERCARD INC AR5L2ODV9HN37376R084 MASTERCARD INC 57636Q104 26095.00 NS USD 12388862.20 2.7847652907452 Long EC CORP US N 1 N N N INGERSOLL RAND INC 5299004C02FMZCUOIR50 INGERSOLL RAND INC 45687V106 127410.00 NS USD 11636355.30 2.6156169813737 Long EC CORP US N 1 N N N NVIDIA CORP 549300S4KLFTLO7GSQ80 NVIDIA CORP 67066G104 33473.00 NS USD 26481159.76 5.9524283479662 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 90470.00 NS USD 37422010.80 8.4117100588732 Long EC CORP US N 1 N N N AMAZON.COM INC ZXTILKJKG63JELOEG630 AMAZON.COM INC 023135106 127016.00 NS USD 22451348.16 5.0466083226275 Long EC CORP US N 1 N N N ACCENTURE PLC 5493000EWHDSR3MZWH98 ACCENTURE PLC N/A 32841.00 NS USD 12308149.98 2.7666228184853 Long EC CORP IE N 1 N N N APPLE INC HWUPKR0MPOU8FGXBT394 APPLE INC 037833100 131704.00 NS USD 23805498.00 5.3509937788561 Long EC CORP US N 1 N N N ALPHABET INC 5493006MHB84DD0ZWV18 ALPHABET INC 02079K305 147790.00 NS USD 20463003.40 4.599668693766 Long EC CORP US N 1 N N N COSTCO WHOLESALE CORP 29DX7H14B9S6O3FD6V18 COSTCO WHOLESALE CORP 22160K105 20301.00 NS USD 15101710.89 3.3945587285119 Long EC CORP US N 1 N N N CF INDUSTRIES HOLDINGS INC 529900CG8YAQFZ2JMV97 CF INDUSTRIES HOLDINGS INC 125269100 60400.00 NS USD 4875488.00 1.0959109511965 Long EC CORP US N 1 N N N CMS ENERGY CORP 549300IA9XFBAGNIBW29 CMS ENERGY CORP 125896100 110027.00 NS USD 6312248.99 1.4188657206869 Long EC CORP US N 1 N N N DREYFUS INSTITUTIONAL PREFERRE 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Plus Money Market Fund 26200T208 4539295.39 OU Other Units USD 4539295.39 1.0203416619253 Long STIV RF US N 1 2099-12-01 Variable 5.410954 N N N N N N 2024-04-17 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10743bnymello-february20241.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon Sustainable U.S. Equity Fund, Inc.

February 29, 2024 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0%

     

Banks - 4.2%

     

First Horizon Corp.

   

281,479

 

3,968,854

 

JPMorgan Chase & Co.

   

80,069

 

14,897,638

 
    

18,866,492

 

Capital Goods - 7.9%

     

Hubbell, Inc.

   

20,076

 

7,642,331

 

Ingersoll Rand, Inc.

   

127,410

 

11,636,355

 

Johnson Controls International PLC

   

126,851

 

7,518,459

 

Trane Technologies PLC

   

30,166

 

8,505,907

 
    

35,303,052

 

Commercial & Professional Services - 2.6%

     

Veralto Corp.

   

37,643

 

3,253,108

 

Waste Management, Inc.

   

39,995

 

8,224,972

 
    

11,478,080

 

Consumer Discretionary Distribution & Retail - 5.1%

     

Amazon.com, Inc.

   

127,016

a 

 22,451,348

 

Consumer Durables & Apparel - 1.5%

     

Lululemon Athletica, Inc.

   

14,572

a 

 6,806,436

 

Consumer Staples Distribution - 3.4%

     

Costco Wholesale Corp.

   

20,301

 

 15,101,711

 

Financial Services - 5.1%

     

Mastercard, Inc., Cl. A

   

26,095

 

12,388,862

 

The Goldman Sachs Group, Inc.

   

25,909

 

10,079,896

 
    

22,468,758

 

Food, Beverage & Tobacco - 3.2%

     

Darling Ingredients, Inc.

   

98,735

a 

4,177,478

 

PepsiCo, Inc.

   

61,724

 

10,205,446

 
    

14,382,924

 

Health Care Equipment & Services - 5.8%

     

Boston Scientific Corp.

   

205,921

a 

13,634,029

 

DexCom, Inc.

   

45,723

a 

5,261,346

 

UnitedHealth Group, Inc.

   

14,195

 

7,006,652

 
    

25,902,027

 

Insurance - 4.0%

     

RenaissanceRe Holdings Ltd.

   

36,213

 

8,141,407

 

The Progressive Corp.

   

51,357

 

9,735,233

 
    

17,876,640

 

Materials - 2.5%

     

CF Industries Holdings, Inc.

   

60,400

 

4,875,488

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0% (continued)

     

Materials - 2.5% (continued)

     

Ecolab, Inc.

   

28,426

 

6,391,302

 
    

11,266,790

 

Media & Entertainment - 4.6%

     

Alphabet, Inc., Cl. A

   

147,790

a 

 20,463,003

 

Pharmaceuticals, Biotechnology & Life Sciences - 10.2%

     

AbbVie, Inc.

   

65,893

 

11,600,463

 

BioMarin Pharmaceutical, Inc.

   

43,257

a 

3,732,214

 

Danaher Corp.

   

39,747

 

10,061,556

 

Eli Lilly & Co.

   

17,388

 

13,104,988

 

Zoetis, Inc.

   

34,059

 

6,754,922

 
    

45,254,143

 

Semiconductors & Semiconductor Equipment - 10.4%

     

Applied Materials, Inc.

   

45,326

 

9,138,628

 

Micron Technology, Inc.

   

63,592

 

5,762,071

 

NVIDIA Corp.

   

33,473

 

26,481,160

 

Texas Instruments, Inc.

   

28,535

 

4,774,762

 
    

46,156,621

 

Software & Services - 18.7%

     

Accenture PLC, Cl. A

   

32,841

 

12,308,150

 

Akamai Technologies, Inc.

   

56,345

a 

6,249,787

 

Intuit, Inc.

   

19,087

 

12,652,581

 

Microsoft Corp.

   

90,470

 

37,422,011

 

PTC, Inc.

   

29,347

a 

5,370,794

 

Roper Technologies, Inc.

   

16,722

 

9,108,975

 
    

83,112,298

 

Technology Hardware & Equipment - 7.0%

     

Apple, Inc.

   

131,704

 

23,805,498

 

TE Connectivity Ltd.

   

50,240

 

7,212,454

 
    

31,017,952

 

Utilities - 2.8%

     

CMS Energy Corp.

   

110,027

 

6,312,249

 

NextEra Energy, Inc.

   

109,556

 

6,046,396

 
    

12,358,645

 

Total Common Stocks (cost $260,424,072)

   

440,266,920

 
  

1-Day
Yield (%)

     

Investment Companies - 1.0%

     

Registered Investment Companies - 1.0%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares
(cost $4,539,295)

 

5.41

 

4,539,295

b 

 4,539,295

 

Total Investments (cost $264,963,367)

 

100.0%

 

444,806,215

 

Cash and Receivables (Net)

 

.0%

 

73,727

 


      

Net Assets

 

100.0%

 

444,879,942

 

a Non-income producing security.

b Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS (Unaudited) (continued)

The following is a summary of the inputs used as of February 29, 2024 in valuing the fund’s investments:

       
 

Level 1-Unadjusted Quoted Prices

Level 2- Other Significant Observable Inputs

 

Level 3-Significant Unobservable Inputs

Total

 

Assets ($) 

  

Investments in Securities:

  

Equity Securities - Common Stocks

440,266,920

-

 

-

440,266,920

 

Investment Companies

4,539,295

-

 

-

4,539,295

 

 See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

The fund’s Board of Directors (the “Board”) has designated the Adviser as the fund’s valuation designee to make all fair value determinations with respect to the fund’s portfolio investments, subject to the Board’s oversight and pursuant to Rule 2a-5 under the Act.


Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

At February 29, 2024, accumulated net unrealized appreciation on investments was $179,842,848, consisting of $187,089,292 gross unrealized appreciation and $7,246,444 gross unrealized depreciation.


At February 29, 2024, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.